Sub-Saharan African region news, resources and funding for global health researchers
NIH supports a diverse mix of research projects in Sub-Saharan Africa with significant activities in approximately 20 African countries. About a third of the funding supports groundbreaking research and research training on HIV/AIDS and sexually transmitted diseases, including a substantial effort to study mother-to-child transmission of HIV. Around 20 percent funds research on other infectious diseases, ranging from population-based research on malaria, schistosomiasis and leishmaniasis, to molecular research on vectors and parasites. Chronic disease research makes up about 12 percent of the research portfolio, with the remainder devoted to child development, biodiversity, basic research and other studies.
Countries in Region
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Republic of Congo, Côte d’Ivoire, Djibouti, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Libya, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Morocco, Namibia, Niger, Nigeria, Rwanda, São Tomé and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Zambia, Zimbabwe
NIH Funded Research Impacting Sub-Saharan Africa
- Through grant funding to U.S. universities, NIH facilitates international collaboration in Sub-Saharan Africa in all areas of the biomedical and behavioral sciences.
Fogarty/NIH News
- Screening for Hypertension in adolescents living with HIV: Protocol for a cluster randomized trial to improve guideline adherence, co-authored by Fogarty grant recipient Elijah Paintsil
PLOS One, May 3, 2023
-
Global Health Matters, March/April 2024
-
Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017–2019
Emerging Infectious Diseases, April 2024 -
Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions
Emerging Infectious Diseases, April 2024 -
Co-Circulating Monkeypox and Swinepox Viruses, Democratic Republic of the Congo, 2022
Emerging Infectious Diseases, April 2024 -
At 20, the African Journal Partnership Program Enters Young Adulthood
National Library of Medicine’s Musing From the Mezzanine blog, April 3, 2024 -
Experimental Ebola Vaccines Found Safe and Capable of Producing Immune Responses in Healthy Adults
NIAID news, April 3, 2024 -
ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study, co-authored by Fogarty Emerging Global Leader Tamsin Kate Phillips
Journal of the International AIDS Society, April 2, 2024 -
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation, co-authored by Fogarty grant recipients Kazione Kulisewa and Bradley Gaynes, and Fogarty trainee Michael Udedi
The Lancet Global Health, April 1, 2024
Funding/Training Opportunities
U.S. Government Resources
Other Resources
Fogarty Contact
Stacy Wallick, MPH
Regional Program Director, Sub-Saharan Africa
Division of International Relations
Fogarty International Center
National Institutes of Health
Building 31 Room B2C11
Bethesda, MD 20892-2220
Telephone: 301-496-2091
FAX: 301-480-3414
Email (preferred):
Stacy.Wallick@nih.gov
Updated May 9, 2024